Revofil is a line of biorevitalising implants intended to rejuvenate skin affected by early signs of ageing like dullness, dryness, and sagging skin. These solutions are also great for keeping noticeable lines and wrinkles at bay.
All of the abovementioned fillers must be kept in a clean environment in temperatures ranging between 2°C to 25°C. The Revofil range of products is manufactured by Caregen.
These non-surgical aesthetic fillers are indicated for correcting skin affected by minor imperfections caused by premature ageing. It involves administering bioactive ingredients like hyaluronic acid, multi-vitamins, enzymes, and amino acids intradermally to stimulate efficient skin cells functions. The areas of treatment and function of each of the fillers is as follows:
These implants contain ingredients, including hyaluronic acid, to help moisturise dry and dull skin at a cellular level. Immediately after injection, the solution will plump up the treated skin, resulting in the subtle disappearance of fine lines. The hyaluronic acid, together with other ingredients such as amino acids, peptides, and multivitamins, boosts hydration for a radiant appearance. By stimulating these functions, a firmer framework is created, and the treated skin appears brighter, smoother, and plumper.
Though it may seem like a simple procedure, mesotherapy treatment sessions must adhere to the same aseptic standards as any other medical procedure. This involves disinfecting the proposed treatment areas and assembling the medical device with great care. These injections should only be administered by a certified medical practitioner with experience in aesthetic treatments. Aquashine and Aquashine BR implants must be administered intradermally via superficial to mid dermal injections. Aquashine BTX must be implanted via mid to deep dermal injections. After adequate correction, gently massage the treated areas for optimal gel integration, and then safely dispose of any leftover filler and used needles.
For best results, administer Revofil Aquashine and Revofil Aquashine BR in 3 sessions, with a 4-week break between each session. After the initial treatment schedule is completed, you may repeat injections twice or thrice annually depending on the patient’s skin conditions and progress. When administering Aquashine BTX, there should be a minimum time interval of 4 weeks between the first and subsequent treatment. The optimal maintenance regimen depends solely on the patient’s age, skin conditions, and lifestyle.
Yes, the Revofil range of products is indeed very safe and is the ideal treatment for patients seeking effective skin rejuvenating actions. The implants have been purified and checked for quality before becoming available to patients. Nevertheless, there are some contraindications that must be observed to ensure safety.
Refer to the package insert for a detailed list of contraindications.
Patients may exhibit some common inflammatory responses associated with intradermal injections.
These common reactions should subside within a week. Advise your patients of appropriate aftercare methods.
Inaccurate injection techniques may lead to rare but severe reactions.
Patients must seek medical assistance if any of the symptoms persist or exacerbate. Refer to the package insert for a detailed list of side effects.
Revofil Aquashine Soft Filler and Revofil Aquashine BR Soft Filler are composed of hyaluronic acid and a skin rejuvenating complex that includes 4 peptides, 24 amino acids, 14 vitamins, and 8 minerals and coenzymes. Revofil Aquashine BTX contains sodium hyaluronate and a biomimetic peptide complex containing 7 peptides.